亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
senli2018发布了新的文献求助10
1秒前
Persist完成签到,获得积分10
27秒前
57秒前
852应助车哥爱学习采纳,获得10
59秒前
vivi发布了新的文献求助10
1分钟前
xiangcaiyang发布了新的文献求助10
1分钟前
1分钟前
SciGPT应助xx采纳,获得10
1分钟前
1分钟前
xx发布了新的文献求助10
1分钟前
21完成签到,获得积分10
2分钟前
冷艳的裙子完成签到 ,获得积分10
2分钟前
CodeCraft应助xx采纳,获得10
2分钟前
2分钟前
xx发布了新的文献求助10
2分钟前
zxq完成签到 ,获得积分10
2分钟前
旺仔先生完成签到 ,获得积分10
2分钟前
xx完成签到,获得积分10
2分钟前
菲子笑完成签到,获得积分10
3分钟前
四氧化三铁完成签到,获得积分10
3分钟前
Ava应助咕咕采纳,获得10
3分钟前
3分钟前
andi完成签到,获得积分10
3分钟前
咕咕发布了新的文献求助10
3分钟前
大木头完成签到 ,获得积分10
3分钟前
陆上飞完成签到,获得积分10
4分钟前
navon完成签到,获得积分10
4分钟前
大个应助david_guo采纳,获得10
4分钟前
葛力完成签到,获得积分10
5分钟前
研友_LMo56Z完成签到,获得积分10
5分钟前
咔敏完成签到 ,获得积分10
5分钟前
5分钟前
joy001发布了新的文献求助10
5分钟前
ChangShengtzu完成签到 ,获得积分10
5分钟前
ZanE完成签到,获得积分10
5分钟前
Jason发布了新的文献求助10
6分钟前
搜集达人应助Jason采纳,获得10
6分钟前
Akim应助meeteryu采纳,获得30
6分钟前
flyinthesky完成签到,获得积分10
6分钟前
6分钟前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7297664
求助须知:如何正确求助?哪些是违规求助? 8916125
关于积分的说明 18879159
捐赠科研通 6963159
什么是DOI,文献DOI怎么找? 3210584
关于科研通互助平台的介绍 2379896
邀请新用户注册赠送积分活动 2187087